Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11766470 Manufacture, formulation and dosing of apraglutide

Patent 11766470 was granted and assigned to VectivBio on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Gleb Feldman

Federico Bolognani

Date of Patent

September 26, 2023

Patent Application Number

18164335

Date Filed

February 3, 2023

Patent Citations

US Patent 9580487 Method of treating stomach or bowel-related disorders by administering glucagon-like-peptide-2 (GLP-2) analogues

US Patent 10253080 Glucagon-like-peptide-2 (GLP-2) analogues

US Patent 9782455 Solid phase synthesis of h(Gly2)GLP-2

US Patent 7847061 Treatment of short bowel syndrome patients with colon-in-continuity

US Patent 8580918 Peptidic GLP-2 agonists

US Patent 8589918 Multi-platform compatible portable virtual machine player

US Patent 9060992 Treatment of short bowel syndrome patients with colon-in-continuity

US Patent 9545434 Treatment of short bowel syndrome patients with colon-in-continuity

Patent Primary Examiner

Sudhakar Katakam

CPC Code

Patent abstract

The present disclosure relates to methods of making, formulating and administering GLP-2 analogs.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11766470 Manufacture, formulation and dosing of apraglutide

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool